+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Proteomics Market Global Report 2020-30

  • ID: 5014060
  • Report
  • April 2020
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • Bruker Corporation
  • Creative Proteomics
  • GE Healthcare
  • LI-COR, Inc.
  • Merck KGaA
  • Promega Corporation
Proteomics Market Global Report 2020-30 from the author provides the strategists, marketers and senior management with the critical information they need to assess the global proteomics market.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3 working days of order.

Description:

Where is the largest and fastest growing market for the proteomics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Proteomics market global report from the author answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider proteomics market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The proteomics market section of the report gives context. It compares the proteomics market with other segments of the proteomics market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, proteomics indicators comparison.

Scope

Markets Covered: 1) By Component: Reagents; Instruments; 2) By Instrument: Protein Microarrays; Spectroscopy; X-ray Crystallography; Chromatography; Electrophoresis; Surface Plasmon Resonance; Protein Fractionation; 3) By Service and Software: Core Proteomics Services; Bioinformatics Software & Services

Companies Mentioned: Thermo Fisher Scientific, Inc.; Agilent Technologies, Inc.; Danaher Corporation; Merck KGaA; Waters Corporation

Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA and Australia

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bruker Corporation
  • Creative Proteomics
  • GE Healthcare
  • LI-COR, Inc.
  • Merck KGaA
  • Promega Corporation

1. Executive Summary2. Proteomics Market Characteristics
3. Proteomics Market Size And Growth
3.1. Global Proteomics Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Proteomics Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Proteomics Market Segmentation
4.1. Global Proteomics Market, Segmentation By Component, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Reagents
Instruments
4.2. Global Proteomics Market, Segmentation By Instrument, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Protein Microarrays
  • Spectroscopy
  • X-ray Crystallography
  • Chromatography
  • Electrophoresis
  • Surface Plasmon Resonance
  • Protein Fractionation
  • 4.3. Global Proteomics Market, Segmentation By Service and Software, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Core Proteomics Services
  • Bioinformatics Software & Services

5. Proteomics Market Regional And Country Analysis
5.1. Global Proteomics Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Proteomics Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6. Asia-Pacific Proteomics Market
6.1. Asia-Pacific Proteomics Market Overview
6.2. Asia-Pacific Proteomics Market, Segmentation By Component, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
7. China Proteomics Market
7.1. China Proteomics Market Overview
7.2. China Proteomics Market, Segmentation By Component, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
8. India Proteomics Market
8.1. India Proteomics Market Overview
8.2. India Proteomics Market, Segmentation By Component, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9. Japan Proteomics Market
9.1. Japan Proteomics Market Overview
9.2. Japan Proteomics Market, Segmentation By Component, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10. Australia Proteomics Market
10.1. Australia Proteomics Market, Segmentation By Component, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11. Indonesia Proteomics Market
11.1. Indonesia Proteomics Market, Segmentation By Component, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12. South Korea Proteomics Market
12.1. South Korea Proteomics Market, Segmentation By Component, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13. Western Europe Proteomics Market
13.1. Western Europe Proteomics Market Overview
13.2. Western Europe Proteomics Market, Segmentation By Component, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14. UK Proteomics Market
14.1. UK Proteomics Market Overview
14.2. UK Proteomics Market, Segmentation By Component, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15. Germany Proteomics Market
15.1. Germany Proteomics Market, Segmentation By Component, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16. France Proteomics Market
16.3. France Proteomics Market, Segmentation By Component, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17. Eastern Europe Proteomics Market
17.1. Eastern Europe Proteomics Market Overview
17.2. Eastern Europe Proteomics Market, Segmentation By Component, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18. Russia Proteomics Market
18.1. Russia Proteomics Market, Segmentation By Component, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19. North America Proteomics Market
19.1. North America Proteomics Market Overview
19.2. North America Proteomics Market, Segmentation By Component, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20. USA Proteomics Market
20.1. USA Proteomics Market Overview
20.2. USA Proteomics Market, Segmentation By Component, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21. South America Proteomics Market
21.1. South America Proteomics Market Overview
21.2. South America Proteomics Market, Segmentation By Component, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22. Brazil Proteomics Market
22.1. Brazil Proteomics Market, Segmentation By Component, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23. Middle East Proteomics Market
23.1. Middle East Proteomics Market Overview
23.2. Middle East Proteomics Market, Segmentation By Component, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24. Africa Proteomics Market
24.1. Africa Proteomics Market Overview
24.2. Africa Proteomics Market, Segmentation By Component, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
25. Proteomics Market Competitive Landscape And Company Profiles
25.1. Proteomics Market Competitive Landscape
25.2. Proteomics Market Company Profiles
25.2.1. Thermo Fisher Scientific, Inc.
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Agilent Technologies, Inc.
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Danaher Corporation
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Merck KGaA
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Waters Corporation
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance
26. Key Mergers And Acquisitions In The Proteomics Market27. Proteomics Market Trends And Strategies28. Proteomics Market Future Outlook and Potential Analysis
29. Appendix
29.1. Abbreviations
29.2. Currencies
29.3. Research Inquiries
29.4. About the Publisher
29.5. Copyright And Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bruker Corporation
  • Creative Proteomics
  • GE Healthcare
  • LI-COR, Inc.
  • Merck KGaA
  • Promega Corporation
The proteomics market consists of sales of proteomics and related goods. Proteomics is a study of the structure and functions of proteins that are used in drug discovery, diagnosis, and treatment of diseases. Proteomics is used to evaluate the protein production rate, the involvement of proteins in metabolic pathways, and modifications of proteins.

The global proteomics market was worth $18.01 billion in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 14.79% and reach $31.28 billion by 2023.

The proteomics market has been geographically segmented into North America, Western Europe, Asia-Pacific, Eastern Europe, South America and Middle East & Africa. North America was the largest market And Asia Pacific is the fastest growing market.

The proteomics market covered in this report is segmented by component into reagents; instruments. It is also segmented by instrument into protein microarrays; spectroscopy; X-Ray crystallography; chromatography; electrophoresis; surface plasmon resonance; protein fractionation and by service and software into core proteomics services; bioinformatics software & services.

Rising government funds for research on proteomics drives the growth of the proteomics market. Government funds help researchers in drug discovery, diagnosis, and treatment of diseases. For instance, in 2018, in Australia, according to the Australian Cancer Research Foundation, the NSW and Commonwealth Governments jointly gave funds of $41 million to support the world-first proteomics project, ProCan. ProCan is an ACRF seed-funded cancer research project at the Westmead Children’s Medical Research Institute (CMRI) and the joint investment enhances research to outsmart cancer. Therefore, rising government funds positively impacts the proteomics market.

The high cost of instruments is expected to limit the growth of the proteomics market. The broad implementation of new technologies expands the use of proteomics research from the discovery of new drugs, vaccines and diagnostic targets, and due to its high cost process, developments in different instruments have resulted in high prices compared to the traditional ones. For instance, the price of mass spectrometers can range from $20,000 to $300,000, which will be extremely expensive for small-scale pharmaceutical companies and academic institutions. Therefore, the high prices associated with proteomics instruments makes it difficult for developing countries to enter the proteomics sector, affecting the market’s growth.

Companies are launching new products in order to increase their revenue and also gain a competitive edge over their rivals. For instance, in June 2018, Bruker Corporation, a USA-based scientific instruments manufacturing company, launched a wide range of mass spectrometry devices, such as scimaXTM Magnetic Resonance Mass Spectrometer (MRMS), which is designed for enabling high throughput. The MRMS has mass resolution exceeding 20 million, in a smaller footprint and without the need for any liquid cryogens. Using MRMS, Biopharma users can perform advanced native protein and fragment-based drug discovery studies, which has recently been called a “bona-fide” platform for native protein analysis in the scientific literature.

In January 2020, Abcam, a UK-based company specialized in manufacturing research grade antibodies, acquired Expedeon's Proteomics and Immunology Business for an undisclosed amount. The acquisition is expected to help Abcam to enhance its protein conjugation technology and to create new products for supporting research and diagnostic development. Expedeon Ltd. is a UK-based company that specializes in the development of next-generation tools for biological research, diagnostics, and drug discovery.

Major players in the market are Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Danaher Corporation, Merck KGaA, Waters Corporation, Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Bruker Corporation, GE Healthcare and Caprion Biosciences.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • Merck KGaA
  • Waters Corporation
  • Perkinelmer, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • GE Healthcare
  • Caprion Biosciences
  • Luminex Corporation
  • LI-COR, Inc.
  • Becton, Dickinson and Company
  • Siemens Ltd
  • Genzyme Corporation
  • Creative Proteomics
  • Promega Corporation
Note: Product cover images may vary from those shown

Loading
LOADING...